UnitedHealth Group stock plunged on rising medical costs, leadership shifts, and a DOJ probe, plus 2025 guidance withdrawal.

UNH's dip to $250 offers a strong buy opportunity with solid revenue growth, resilient dividends, and historic low P/E.

Below is Validea's guru fundamental report for UNITEDHEALTH GROUP INC (UNH). Of the 22 guru strategies ... underlying fundamentals and the stock’s valuation. A score of 80% or above typically ...

Below is Validea's guru fundamental report for UNITEDHEALTH GROUP INC (UNH). Of the 22 guru strategies ... underlying fundamentals and the stock’s valuation. A score of 80% or above typically ...

Wells Fargo slashes the three-year logged-in DAU growth outlook to 10% from 13%, citing reduced user acquisition potential. The bank doubts Reddit can meet ad growth expectations on logged-in users ...

We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not ...

UnitedHealth (UNH) stock is surging after its CEO bought $25 million in stock, even as the company faces legal and leadership challenges. Mizuho Americas healthcare equity strategist Jared Holz joins ...

UnitedHealth Group (UNH) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some ...

S&P 500, Northern Trust Corporation, Unitedhealth Group, Hims Hers Health Inc. Read 's Market Analysis on Investing.com ...

UnitedHealth's strategy of providing medical insurance, pharmacy benefits, and healthcare services should create a powerful alignment of incentives to help clients control their healthcare costs ...

UnitedHealth (UHS) shares have crashed in recent weeks amidst a tirade of bad news, including allegations that it made bonus ...

Analyst Justin Lake cut the price target after the company announced guidance suspension. During the Q1 FY2025 earnings call, ...